OPTAFLU Trademark

Trademark Overview

On Thursday, July 9, 2015, a trademark application was filed for OPTAFLU with the United States Patent and Trademark Office. The USPTO has given the OPTAFLU trademark a serial number of 86688595. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 18, 2023. This trademark is owned by Novartis AG. The OPTAFLU trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
optaflu

General Information

Serial Number86688595
Word MarkOPTAFLU
Filing DateThursday, July 9, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 18, 2023
Registration Number5135324
Registration DateTuesday, February 7, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2016

Trademark Statements

Goods and ServicesVaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 18, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSEQIRUS UK LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMAIDENHEAD, BERKSHIRE SL6 8AA
GB
Party NameSEQIRUS UK LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMAIDENHEAD, BERKSHIRE SL6 8AA
GB
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Friday, August 18, 2023CANCELLED SEC. 8 (6-YR)
Monday, February 7, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 7, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, November 22, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 2, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 17, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 14, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 13, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 13, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 6, 2016ASSIGNED TO LIE
Thursday, September 29, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 29, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 28, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 28, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 9, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 9, 2016NON-FINAL ACTION E-MAILED
Tuesday, August 9, 2016NON-FINAL ACTION WRITTEN
Monday, August 1, 2016PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, July 22, 20161(B) BASIS DELETED; NEW BASIS REQUESTED
Friday, July 8, 2016NOTICE OF ALLOWANCE CANCELLED
Friday, July 22, 2016PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, July 19, 2016ASSIGNED TO PETITION STAFF
Friday, July 8, 2016TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, January 12, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 17, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 17, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 28, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 6, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 5, 2015ASSIGNED TO EXAMINER
Tuesday, July 14, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 13, 2015NEW APPLICATION ENTERED

Related Keywords

optaflu human vaccines